LGND stock

Ligand Pharmaceuticals Incorporated (LGND) valuation · P/E 126, rev $268.1M

Ligand Pharmaceuticals Incorporated (LGND) P/E 126, rev $268.1M.

Valuation multiples
MetricValue
P/E126
Market cap$2.21B
Revenue$268.1M
P/S8.2
These valuation metrics as JSON? API free 100/day

LGND valuation FAQ

What is LGND's P/E ratio?

Ligand Pharmaceuticals Incorporated (LGND) trailing P/E is 126 on the latest cached fundamentals snapshot.

What is LGND's market cap?

Ligand Pharmaceuticals Incorporated (LGND) market cap is $2.21B on the latest cached fundamentals snapshot.

What is LGND's latest revenue?

Latest cached Ligand Pharmaceuticals Incorporated (LGND) revenue was $268.1M. Statements: https://lician.com/financials/lgnd

What is LGND's price-to-sales ratio?

Ligand Pharmaceuticals Incorporated (LGND) price-to-sales (P/S) is 8.2, cached market cap $2.21B divided by revenue $268.1M.

How many LGND valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Ligand Pharmaceuticals Incorporated (LGND): P/E, Market cap, Revenue, and P/S.

Where is LGND valuation listed?

Cached valuation multiples for Ligand Pharmaceuticals Incorporated (LGND) are listed at https://lician.com/valuation/lgnd.

Not investment advice. Figures as filed or reported, not a live feed.